Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 23, 2024The Journal of Immunology

IDO1 Inhibition Promotes Activation of Tumor-intrinsic STAT3 Pathway and Induces Adverse Tumor-protective Effects

View Full Paper
Ask AI
Bookmark
Share

Authors

LYLong‐Bo YuState Key Laboratory of Synthetic ChemistryLXLingyan XuShanghai Jiao Tong UniversityYCY ChenChina Pharmaceutical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yu et al. (2024) studied this question.

synapsesocial.com/papers/68e77de8b6db6435876f1686https://doi.org/10.4049/jimmunol.2300545
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell Proliferation2000 · 749 citations
  2. 2Prognostic significance of nuclear pSTAT3 in oral cancer2010 · 106 citations
  3. 3The JAK/STAT signaling pathway2004 · 1,912 citations
  4. 4Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy2021 · 385 citations
  5. 5An adverse tumor-protective effect of IDO1 inhibition2023 · 34 citations